892843-59-3

Basic information

• Product Name: Methyl 2-methylbiphenyl-4-carboxylate
• Synonyms: Methyl 2-methylbiphenyl-4-carboxylate
• CAS NO: 892843-59-3
• Molecular Formula: C15H14O2
• Molecular Weight: 226.27046
• Mol File: 892843-59-3.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Methyl 2-methylbiphenyl-4-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-methylbiphenyl-4-carboxylate(892843-59-3)
• EPA Substance Registry System: Methyl 2-methylbiphenyl-4-carboxylate(892843-59-3)

Safety Data

• Hazardous Substances Data: 892843-59-3(Hazardous Substances Data)

Usage

General Description

Methyl 2-methylbiphenyl-4-carboxylate is a chemical compound that belongs to the ester class of organic compounds. It is commonly used as a fragrance ingredient in perfumes and other scented products. This chemical is also known for its potential application in pharmaceuticals and agrochemicals. Methyl 2-methylbiphenyl-4-carboxylate is synthesized by esterifying 2-methylbiphenyl-4-carboxylic acid with methanol in the presence of an acidic catalyst. It has a fruity, floral odor and is often described as having a sweet, jasmine-like aroma.

Upstream product

• 79-24-3 Nitroethane 
• 5443-49-2 α-bromocinnamaldehyde 
• 104901-43-1 methyl 3-bromo-4-methylbenzoate 
• 98-80-6 phenylboronic acid 
• 148547-19-7 4-Bromo-3-methylbenzoic acid methyl ester 
• 5471-81-8 methyl 4-iodo-3-methylbenzoate 
• 118446-44-9 3-hydroxy-5-methyl-4-phenyl benzoic acid methyl ester 

Downstream Products

• 178313-67-2 2-methyl[1,1'-biphenyl]-4-carboxylic acid 

Relevant articles and documents

Synthesis of 1,3,4-Trisubstituted Benzenes from Morita-Baylis-Hillman Adducts of α-Bromocinnamaldehyde via [5+1] Annulation Strategy

-

ANTIPROLIFERATIVE BENZO [B] AZEPIN- 2 - ONES

Disclosed are compounds of Formula (I) or pharmaceutically acceptable salts thereof, wherein W, X, Y, Z, R1, R2, R3 and R4 are described in this application, and methods of using said compounds in the treatment of cancer.

AMINO ACID COMPOUNDS

[Problem] To provide novel compounds that are S1P1 receptor agonists and exhibit an immunosuppressive activities by inducing lymphocyte sequestration in secondary lymphoid tissues. In addition, to provide a pharmaceutical agent which comprises the compounds as an effective component, in particular to provide a therapeutic and/or prophylactic agent for an autoimmune disease and the like. [Solving Means] Amino acid compounds that are represented by the following Formula (1) are provided